Universe Pharmaceuticals (UPC) Short-term Investments (2021 - 2024)
Historic Short-term Investments for Universe Pharmaceuticals (UPC) over the last 4 years, with Q3 2024 value amounting to $1.4 billion.
- Universe Pharmaceuticals' Short-term Investments rose 10069155.73% to $1.4 billion in Q3 2024 from the same period last year, while for Sep 2024 it was $1.4 billion, marking a year-over-year increase of 10069155.73%. This contributed to the annual value of $1.4 billion for FY2024, which is 10069155.73% up from last year.
- Per Universe Pharmaceuticals' latest filing, its Short-term Investments stood at $1.4 billion for Q3 2024, which was up 10069155.73% from $2.5 million recorded in Q1 2024.
- Universe Pharmaceuticals' Short-term Investments' 5-year high stood at $1.4 billion during Q3 2024, with a 5-year trough of $1.4 million in Q3 2023.
- Its 4-year average for Short-term Investments is $205.2 million, with a median of $13.3 million in 2023.
- In the last 5 years, Universe Pharmaceuticals' Short-term Investments crashed by 8960.31% in 2023 and then soared by 10069155.73% in 2024.
- Universe Pharmaceuticals' Short-term Investments (Quarter) stood at $13.7 million in 2021, then fell by 4.2% to $13.1 million in 2022, then plummeted by 89.6% to $1.4 million in 2023, then skyrocketed by 100691.56% to $1.4 billion in 2024.
- Its Short-term Investments stands at $1.4 billion for Q3 2024, versus $2.5 million for Q1 2024 and $1.4 million for Q3 2023.